Personalized Cell Therapies Market by Cell Type (Hematopoietic Stem Cell, Skeletal Muscle Stem Cell, Mesenchymal Stem Cells, Lymphocytes, Others), By Application (Cardiovascular Disorders, Diabetes, Neurological Disorders, Cancer, Others), and Geography (North America, Latin America, Europe, Asia Pacific and Middle East and Africa)    

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Personalized Cell Therapies Market size was valued at USD 12,252.24 million in 2021, growing at a CAGR of 23.6% from 2022-28. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers engaged in the manufacturing and supply of personalized cell therapies. Research & Development is evolving, various cell types developed into treatments as novel cell therapies due to its potential applications. Bone marrow transplant or hematopoietic stem cell transplant widely used cell therapy due to the treatment of blood cancer. Increased prevalence of cancer, a rise in research and adoption of advanced technologies are expected attract the demand for the market. Key Development: On August 19, 2016, the European Commission has granted conditional marketing authorization for Zalmoxis, patient-specific adjunctive treatment in haploidentical hematopoietic stem cell transplantation for adults with hematological malignancies.  

Global Personalized Cell Therapies Market Summary

Study Period

2023-29

Base Year

2022

CAGR

23.6%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Personalized Cell Therapies Market Dynamics

The rise in prevalence of chronic disorders and unmet needs in current treatment methods are expected to catapult the personalized cell therapies market. Increasing prevalence of various disorders such as diabetes, cancer, autoimmune disorders, neurovascular disorders is expected to create demand for personalized cell therapies market over the forecast period. Moreover, potential applications of cell therapies include treating autoimmune disease, cancers, infectious disease, urinary problems, spinal cord injuries, rebuilding damaged cartilage in joints, improving a weakened immune system, neurological disorders are expected to create lucrative opportunities for the market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Personalized Cell Therapies Market Segmentation

Cell Type
  • Hematopoietic Stem Cell
  • Skeletal Muscle Stem Cell
  • Mesenchymal Stem Cells
  • Lymphocytes
  • Others
Application
  • Cardiovascular Disorders
  • Diabetes
  • Neurological Disorders
  • Cancer
  • Others
Geography
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  1. Research Methodology
    • Secondary and Primary research
      • Secondary Sources
      • Primary Sources
    • Market Revenue Estimation Methodology
    • Key Assumptions
    • Acronyms
  2. Scope of Study
    • Market Definition
    • Objective of the Research
    • Regions covered in the study
  3. Executive summary
  4. Global Personalized Cell Therapy Market Dynamic Factors
    • Drivers
      • Economic Drivers
      • Demand Side Drivers
      • Supply Side Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
  5. Unique Features of the Report
    • Competition analysis
      • Dash board of top players
      • Financial Analysis
      • Product & Services
      • Key Developments
      • Major Strategies
      • SWOT Analysis
    • Technological advancements in personalized cell therapy Market
    • Recent investments in the industry
    • Regulatory landscape
      • S.
      • Europe
    • PESTLE analysis
    • Porter’s analysis
  6. Global Personalized Cell Therapy Market , By Cell Type, 2013 - 2017 and Forecast, 2018 - 2024
    • Hematopoietic Stem Cell
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Skeletal Muscle Stem Cell
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Mesenchymal Stem Cells
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Lymphocytes
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Personalized Cell Therapy Market Forecast, By Application, 2013 - 2017 and Forecast, 2018 – 2024
    • Cardiovascular Disorders
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Diabetes
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Neurological Disorders
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Cancer
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Personalized Cell Therapy Market Forecast, By Region Analysis, 2013 - 2017 and Forecast, 2018 - 2024
    • North America Personalized cell therapy Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
      • Cell Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Hematopoietic Stem Cell
        • Skeletal Muscle Stem Cell
        • Mesenchymal Stem Cell
        • Lymphocytes
        • Others
      • Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Cardiovascular Disorders
        • Diabetes
        • Neurological Disorders
        • Cancer
        • Others
      • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • US
        • Canada
      • Europe Personalized cell therapy Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
        • Cell Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
          • Hematopoietic Stem Cell
          • Skeletal Muscle Stem Cell
          • Mesenchymal Stem Cell
          • Lymphocytes
          • Others
        • Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
          • Cardiovascular Disorders
          • Diabetes
          • Neurological Disorders
          • Cancer
          • Others
        • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
          • Germany
          • UK
          • France
          • Spain
          • Italy
          • Russia
          • Poland
          • Rest of Europe
        • Asia-Pacific Personalized cell therapy Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
          • Cell Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
            • Hematopoietic Stem Cell
            • Skeletal Muscle Stem Cell
            • Mesenchymal Stem Cell
            • Lymphocytes
            • Others
          • Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
            • Cardiovascular Disorders
            • Diabetes
            • Neurological Disorders
            • Cancer
            • Others
          • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and
  1. Y-o-Y Growth (%)
    • Japan
    • China
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of Asia-Pacific
  • Latin America Personalized cell therapy Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
    • Cell Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Hematopoietic Stem Cell
      • Skeletal Muscle Stem Cell
      • Mesenchymal Stem Cell
      • Lymphocytes
      • Others
    • Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Cardiovascular Disorders
      • Diabetes
      • Neurological Disorders
      • Cancer
      • Others
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and
  1. Y-o-Y Growth (%)
    • Brazil
    • Mexico
    • Argentina
    • Venezuela
    • Rest of Latin America
  • Middle East & Africa (MEA) Personalized cell therapy Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
    • Cell Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Hematopoietic Stem Cell
      • Skeletal Muscle Stem Cell
      • Mesenchymal Stem Cell
      • Lymphocytes
      • Others
    • Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Cardiovascular Disorders
      • Diabetes
      • Neurological Disorders
      • Cancer
      • Others
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and
  1. Y-o-Y Growth (%)
    • Gulf Cooperation Council (GCC) Countries
    • Israel
    • South Africa
    • Rest of MEA
  2. Competition Landscape
  • PCT Cell Therapy Services, LLC (U.S)
  • S. Stem Cell, Inc. (U.S)
  • Bellicum Pharmaceuticals, Inc. (U.S)
  • Saneron CCEL Therapeutics, Inc. (U.S)
  • StemGenex (U.S)
  • Vericel Corporation.(U.S)
  • Cytori Therapeutics Inc.(U.S.)
  • MolMed S.p.A. (Italy)